Related Experiment Video
Updated: May 16, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and
Betty Lamothe1, YunJu Lai, Min Xie
1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abstract:
Transforming growth factor β (TGF-β)-activated kinase 1 (TAK1), a mitogen-activated protein 3 (MAP3) kinase, plays an essential role in inflammation by activating the IκB kinase (IKK)/nuclear factor κB (NF-κB) and stress kinase (p38 and c-Jun N-terminal kinase [JNK]) pathways in response to many stimuli. The tumor necrosis factor (TNF) superfamily member receptor activator of NF-κB ligand (RANKL) regulates osteoclastogenesis through its receptor, RANK, and the signaling adaptor TRAF6. Because TAK1 activation is mediated through TRAF6 in the interleukin 1 receptor (IL-1R) and toll-like receptor (TLR) pathways, we sought to investigate the consequence of TAK1 deletion in RANKL-mediated osteoclastogenesis. We generated macrophage colony-stimulating factor (M-CSF)-derived monocytes from the bone marrow of mice with TAK1 deletion in the myeloid lineage. Unexpectedly, TAK1-deficient monocytes in culture died rapidly but could be rescued by retroviral expression of TAK1, inhibition of receptor-interacting protein 1 (RIP1) kinase activity with necrostatin-1, or simultaneous genetic deletion of TNF receptor 1 (TNFR1). Further investigation using TAK1-deficient mouse embryonic fibroblasts revealed that TNF-α-induced cell death was abrogated by the simultaneous inhibition of caspases and knockdown of RIP3, suggesting that TAK1 is an important modulator of both apoptosis and necroptosis. Moreover, TAK1-deficient monocytes rescued from programmed cell death did not form mature osteoclasts in response to RANKL, indicating that TAK1 is indispensable to RANKL-induced osteoclastogenesis. To our knowledge, we are the first to report that mice in which TAK1 has been conditionally deleted in osteoclasts develop osteopetrosis.
Insights
Transforming growth factor β-activated kinase 1 (TAK1) is crucial for osteoclast formation. Its deletion in myeloid cells unexpectedly caused cell death, but rescued cells showed impaired osteoclastogenesis, leading to osteopetrosis.
Area of Science:
- Cell Biology
- Immunology
- Molecular Biology
Background:
- Transforming growth factor β (TGF-β)-activated kinase 1 (TAK1) is a key kinase in inflammatory signaling pathways, including NF-κB and stress kinases.
- Receptor activator of NF-κB ligand (RANKL) signaling is essential for osteoclastogenesis, the process of bone-resorbing cell formation.
- TAK1 activation is known to be mediated by TRAF6 in IL-1R and TLR pathways.
Purpose of the Study:
- To investigate the role of TAK1 in RANKL-mediated osteoclastogenesis.
- To determine the consequences of TAK1 deletion in myeloid cells on osteoclast formation and survival.
Main Methods:
- Generated M-CSF-derived monocytes from mice with myeloid lineage TAK1 deletion.
- Assessed monocyte survival and rescue strategies (retroviral TAK1, RIP1 inhibition, TNFR1 deletion).
- Investigated TNF-α-induced cell death in TAK1-deficient fibroblasts using caspase inhibition and RIP3 knockdown.
- Evaluated RANKL-induced osteoclastogenesis in rescued TAK1-deficient monocytes.
Main Results:
- TAK1-deficient monocytes exhibited rapid cell death, which was rescued by TAK1 re-expression, RIP1 inhibition, or TNFR1 deletion.
- TAK1 deficiency sensitized cells to TNF-α-induced death, modulated by caspases and RIP3, indicating a role in both apoptosis and necroptosis.
- Rescued TAK1-deficient monocytes failed to form mature osteoclasts upon RANKL stimulation.
- Conditional TAK1 deletion in osteoclasts resulted in osteopetrosis in mice.
Conclusions:
- TAK1 is indispensable for RANKL-mediated osteoclastogenesis.
- TAK1 plays a critical role in regulating monocyte survival, apoptosis, and necroptosis.
- Conditional deletion of TAK1 in osteoclasts leads to osteopetrosis, highlighting TAK1's importance in bone metabolism.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Apoptosis
Caspases
Osteoclasts in Bone Remodeling
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...